Anti-Angiogenic and Anti-Scarring Dual Action of an Anti-Fibroblast Growth Factor 2 Aptamer in Animal Models of Retinal Disease
Author:
Funder
The Japan Agency for Medical Research and Development
Publisher
Elsevier BV
Subject
Drug Discovery,Molecular Medicine
Reference58 articles.
1. Stem cell therapy in nonneovascular age-related macular degeneration;Kashani;Invest. Ophthalmol. Vis. Sci.,2016
2. A bioengineered retinal pigment epithelial monolayer for advanced, dry age-related macular degeneration;Kashani;Sci. Transl. Med.,2018
3. Incidence of late-stage age-related macular degeneration in American whites: systematic review and meta-analysis;Rudnicka;Am. J. Ophthalmol.,2015
4. Racial differences in age-related macular degeneration rates in the United States: a longitudinal analysis of a managed care network;Vanderbeek;Am. J. Ophthalmol.,2011
5. Polarized vascular endothelial growth factor secretion by human retinal pigment epithelium and localization of vascular endothelial growth factor receptors on the inner choriocapillaris. Evidence for a trophic paracrine relation;Blaauwgeers;Am. J. Pathol.,1999
Cited by 36 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Comparative Analysis of Molecular Landscape in Mouse Models and Patients Reveals Conserved Inflammation Pathways in Age-Related Macular Degeneration;Investigative Opthalmology & Visual Science;2024-01-04
2. Effects of Humanin G (HNG) on angiogenesis and neurodegeneration markers in Age-related Macular Degeneration (AMD);Mitochondrion;2024-01
3. Safety and tolerability of intravitreal umedaptanib pegol (anti-FGF2) for neovascular age-related macular degeneration (nAMD): a phase 1, open-label study;Eye;2023-12-01
4. Clinical proof of concept for anti-FGF2 therapy in exudative age-related macular degeneration (nAMD): phase 2 trials in treatment-naïve and anti-VEGF pretreated patients;Eye;2023-11-30
5. The Effect of Anti-Autotaxin Aptamers on the Development of Proliferative Vitreoretinopathy;International Journal of Molecular Sciences;2023-11-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3